In this study, we investigated the inhibitory effects of indisulam on MM growth by inducing DNA damage through downregulating the expression of TOP2A, and evaluated the preclinical efficacy of combining indisulam with melphalan both in vitro and in vivo. Here, TOP2A is linked to Miyoshi myopathy.